CVKD vs. RDIV
CVKD (Cadrenal Therapeutics Inc. Common Stock) is a stock, while RDIV (Invesco S&P Ultra Dividend Revenue ETF) is Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index. Over the past 3 years, CVKD returned -50.11%/yr vs 20.00%/yr for RDIV. At a 0.15 correlation, their price movements are largely independent.
Performance
CVKD vs. RDIV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVKD achieves a -56.05% return, which is significantly lower than RDIV's 14.32% return.
CVKD
- 1D
- -2.61%
- 1M
- -42.58%
- YTD
- -56.05%
- 6M
- -59.57%
- 1Y
- -73.49%
- 3Y*
- -50.11%
- 5Y*
- —
- 10Y*
- —
RDIV
- 1D
- 0.46%
- 1M
- 0.59%
- YTD
- 14.32%
- 6M
- 13.60%
- 1Y
- 28.21%
- 3Y*
- 20.00%
- 5Y*
- 11.27%
- 10Y*
- 11.08%
CVKD vs. RDIV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CVKD Cadrenal Therapeutics Inc. Common Stock | -56.05% | -53.21% | 30.56% | -87.04% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 14.32% | 12.36% | 15.17% | 1.94% |
Correlation
The correlation between CVKD and RDIV is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jan 20, 2023 | 0.15 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVKD vs. RDIV — Risk / Return Rank
CVKD
RDIV
CVKD vs. RDIV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cadrenal Therapeutics Inc. Common Stock (CVKD) and Invesco S&P Ultra Dividend Revenue ETF (RDIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVKD | RDIV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.85 | ||
| Sortino ratioReturn per unit of downside risk | -4.32 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.37 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 5.85 | -6.78 |
| Martin ratioReturn relative to average drawdown | -1.71 | 16.68 | -18.39 |
Loading charts...
Drawdowns
CVKD vs. RDIV - Drawdown Comparison
The maximum CVKD drawdown since its inception was -96.52%, which is greater than RDIV's maximum drawdown of -49.97%. Use the drawdown chart below to compare losses from any high point for CVKD and RDIV.
Loading charts...
Drawdown Indicators
| CVKD | RDIV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.52% | -49.97% | -46.55% |
Max Drawdown (1Y)Largest decline over 1 year | -79.01% | -4.84% | -74.17% |
Max Drawdown (3Y)Largest decline over 3 years | -91.17% | -17.91% | -73.26% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.89% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -49.97% | — |
Current DrawdownCurrent decline from peak | -96.52% | -2.08% | -94.44% |
Average DrawdownAverage peak-to-trough decline | -84.80% | -5.84% | -78.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.94% | 1.70% | +41.24% |
Volatility
CVKD vs. RDIV - Volatility Comparison
Cadrenal Therapeutics Inc. Common Stock (CVKD) has a higher volatility of 25.82% compared to Invesco S&P Ultra Dividend Revenue ETF (RDIV) at 4.29%. This indicates that CVKD's price experiences larger fluctuations and is considered to be riskier than RDIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVKD | RDIV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.82% | 4.29% | +21.53% |
Volatility (6M)Calculated over the trailing 6-month period | 68.27% | 9.02% | +59.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.88% | 13.41% | +86.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 102.19% | 17.48% | +84.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 102.19% | 21.88% | +80.31% |
Dividends
CVKD vs. RDIV - Dividend Comparison
CVKD has not paid dividends to shareholders, while RDIV's dividend yield for the trailing twelve months is around 3.71%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVKD Cadrenal Therapeutics Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 3.71% | 3.94% | 4.08% | 3.93% | 3.44% | 3.31% | 4.93% | 3.84% | 4.32% | 4.26% | 2.20% | 4.49% |
Frequently Asked Questions
CVKD and RDIV have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVKD has higher volatility (25.82%) compared to RDIV (4.29%). In terms of maximum drawdown, CVKD dropped -96.52% vs RDIV's -49.97%.
RDIV currently has the higher Sharpe Ratio (2.12 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVKD and RDIV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer